BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 2469964)

  • 1. Induction of angiogenesis during the transition from hyperplasia to neoplasia.
    Folkman J; Watson K; Ingber D; Hanahan D
    Nature; 1989 May; 339(6219):58-61. PubMed ID: 2469964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic co-operation in beta-cell tumorigenesis.
    Pelengaris S; Khan M
    Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development.
    Larcher F; Murillas R; Bolontrade M; Conti CJ; Jorcano JL
    Oncogene; 1998 Jul; 17(3):303-11. PubMed ID: 9690512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
    Gannon G; Mandriota SJ; Cui L; Baetens D; Pepper MS; Christofori G
    Cancer Res; 2002 Jan; 62(2):603-8. PubMed ID: 11809716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and endocrine tumors].
    Dumortier J; Ratineau C; Roche C; Lombard-Bohas C; Chayvialle JA; Scoazec JY
    Bull Cancer; 1999 Feb; 86(2):148-53. PubMed ID: 10066945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A causal role for E-cadherin in the transition from adenoma to carcinoma.
    Perl AK; Wilgenbus P; Dahl U; Semb H; Christofori G
    Nature; 1998 Mar; 392(6672):190-3. PubMed ID: 9515965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
    Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
    J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis.
    Nozawa H; Chiu C; Hanahan D
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12493-8. PubMed ID: 16891410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch to the angiogenic phenotype during tumorigenesis.
    Folkman J; Hanahan D
    Princess Takamatsu Symp; 1991; 22():339-47. PubMed ID: 1726933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphological and immunocytochemical studies of pancreatic multiple endocrine neoplasia type-1].
    Yonemura U; Konishi K; Miazaki I; Miwa K
    Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):811-9. PubMed ID: 6092890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of the microvascular system during multistage tumorigenesis.
    Ryschich E; Schmidt J; Hämmerling GJ; Klar E; Ganss R
    Int J Cancer; 2002 Feb; 97(6):719-25. PubMed ID: 11857345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis.
    Christofori G; Naik P; Hanahan D
    Nature; 1994 Jun; 369(6479):414-8. PubMed ID: 7910953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation, hyperplasia, neogenesis, and neoplasia in the islets of Langerhans.
    Ballian N; Hu M; Liu SH; Brunicardi FC
    Pancreas; 2007 Oct; 35(3):199-206. PubMed ID: 17895838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
    Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
    BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis. Successful growth of tumours.
    Ross R
    Nature; 1989 May; 339(6219):16-7. PubMed ID: 2469961
    [No Abstract]   [Full Text] [Related]  

  • 16. Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas.
    Chen M; Rahman L; Voeller D; Kastanos E; Yang SX; Feigenbaum L; Allegra C; Kaye FJ; Steeg P; Zajac-Kaye M
    Oncogene; 2007 Jul; 26(33):4817-24. PubMed ID: 17297449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.
    Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J
    Oncogene; 2002 Oct; 21(46):7011-26. PubMed ID: 12370823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pancreatic islets in chondrosarcoma. A qualitative and quantitative study in humans.
    Ghosh L; Huvos AG; Miké V
    Am J Pathol; 1973 Apr; 71(1):23-32. PubMed ID: 4121751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
    Inoue M; Hager JH; Ferrara N; Gerber HP; Hanahan D
    Cancer Cell; 2002 Mar; 1(2):193-202. PubMed ID: 12086877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis.
    Müller-Hermelink N; Braumüller H; Pichler B; Wieder T; Mailhammer R; Schaak K; Ghoreschi K; Yazdi A; Haubner R; Sander CA; Mocikat R; Schwaiger M; Förster I; Huss R; Weber WA; Kneilling M; Röcken M
    Cancer Cell; 2008 Jun; 13(6):507-18. PubMed ID: 18538734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.